# SWITCH THERAPEUTICS INC.: Liver-Sparing APOE Inhibitor for the Treatment of Alzheimer's Disease in APOE4 Homozygotes

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | SWITCH THERAPEUTICS INC. |
| Location | SOUTH SAN FRANCISCO, CA |
| Project | Liver-Sparing APOE Inhibitor for the Treatment of Alzheimer's Disease in APOE4 Homozygotes |
| Project number | 1R44AG102082-01 |
| Mechanism | R44 |
| Institute | National Institute on Aging |
| Award | $1,609,473 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-22 to 2028-05-31 |
| UEI | TFCXTNGC7AQ3 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11405930). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.